1. Home
  2. IMAB vs ISOU Comparison

IMAB vs ISOU Comparison

Compare IMAB & ISOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • ISOU
  • Stock Information
  • Founded
  • IMAB 2014
  • ISOU 2016
  • Country
  • IMAB United States
  • ISOU Canada
  • Employees
  • IMAB N/A
  • ISOU N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • ISOU
  • Sector
  • IMAB Health Care
  • ISOU
  • Exchange
  • IMAB Nasdaq
  • ISOU Nasdaq
  • Market Cap
  • IMAB 394.2M
  • ISOU 391.8M
  • IPO Year
  • IMAB 2020
  • ISOU N/A
  • Fundamental
  • Price
  • IMAB $4.39
  • ISOU $10.73
  • Analyst Decision
  • IMAB Strong Buy
  • ISOU
  • Analyst Count
  • IMAB 6
  • ISOU 0
  • Target Price
  • IMAB $7.17
  • ISOU N/A
  • AVG Volume (30 Days)
  • IMAB 1.7M
  • ISOU 77.5K
  • Earning Date
  • IMAB 11-02-2025
  • ISOU 11-26-2025
  • Dividend Yield
  • IMAB N/A
  • ISOU N/A
  • EPS Growth
  • IMAB N/A
  • ISOU N/A
  • EPS
  • IMAB N/A
  • ISOU N/A
  • Revenue
  • IMAB N/A
  • ISOU N/A
  • Revenue This Year
  • IMAB N/A
  • ISOU N/A
  • Revenue Next Year
  • IMAB N/A
  • ISOU N/A
  • P/E Ratio
  • IMAB N/A
  • ISOU N/A
  • Revenue Growth
  • IMAB N/A
  • ISOU N/A
  • 52 Week Low
  • IMAB $0.60
  • ISOU $5.72
  • 52 Week High
  • IMAB $5.90
  • ISOU $11.10
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 59.97
  • ISOU 69.50
  • Support Level
  • IMAB $3.98
  • ISOU $9.64
  • Resistance Level
  • IMAB $4.51
  • ISOU $10.37
  • Average True Range (ATR)
  • IMAB 0.30
  • ISOU 0.67
  • MACD
  • IMAB 0.07
  • ISOU 0.02
  • Stochastic Oscillator
  • IMAB 89.30
  • ISOU 85.00

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About ISOU IsoEnergy Ltd. Common Shares

IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Thorburn Lake, Radio, Geiger, and Larocque East. and others. It operates in Canada, the United States, and Australia.

Share on Social Networks: